Elite Health Systems Inc. Appoints Dr. Haranath Policherla as Non-Executive Director and Ken Minor as Chief Financial Officer

Reuters
Aug 01
Elite Health Systems Inc. Appoints Dr. Haranath Policherla as Non-Executive Director and Ken Minor as Chief Financial Officer

Elite Health Systems Inc. has announced two key management changes. Dr. Haranath Policherla has been appointed to the Company's Board as a non-executive director, effective immediately. Dr. Policherla brings over three decades of experience in neurology and healthcare leadership. Additionally, Ken Minor has been named as the new Chief Financial Officer. Mr. Minor has been associated with the company as a financial advisor and Secretary since April 2024 and has a strong background in financial management. Both appointments were made on July 26, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elite Health Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-024116), on July 31, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10